Study of primary IGF-1 deficiency in Egyptian children with idiopathic short stature
- PMID: 23635650
- DOI: 10.1159/000350824
Study of primary IGF-1 deficiency in Egyptian children with idiopathic short stature
Abstract
Background/aims: Primary insulin-like growth factor-1 (IGF-1) deficiency (IGFD) is defined by low levels of IGF-1 without growth hormone (GH) deficiency and absence of secondary causes. The aim of this study was to evaluate IGF-1 in Egyptian children with idiopathic short stature (ISS) and describe patients with IGFD.
Methods: This cross-sectional study included 50 children with ISS following up at the Diabetes Endocrine and Metabolism Pediatric Unit at Cairo University Pediatric Hospital. Children were included based on the following criteria: (1) short stature with current height standard deviation score (SDS) ≤-2.5; (2) age between 2 and 9 years in boys and 2 and 8 years in girls, and (3) prepubertal status. Exclusion criteria were: (1) identified cause of short stature and (2) pubertal children. IGF-1-deficient children were defined as children without GH deficiency and with IGF-1 levels below the 2.5th percentile.
Results: Among 50 children with ISS, 14 (28%) patients had low IGF-1 levels, consistent with the diagnosis of primary IGFD. When compared with non-IGFD children, IGFD children had lower birth weight SDS (-1.8 vs. -0.7 SDS, p < 0.0001) and lower height SDS (-4.2 vs. -3.1 SDS, p < 0.05) and more delayed bone age (2.6 vs. 1.6 years, p = 0.001).
Conclusion: Primary IGF-1 deficiency is found in 28% of children with ISS.
Copyright © 2013 S. Karger AG, Basel.
Similar articles
-
Prevalence of IGF1 deficiency in prepubertal children with isolated short stature.Eur J Endocrinol. 2009 Jul;161(1):43-50. doi: 10.1530/EJE-08-0964. Epub 2009 May 5. Eur J Endocrinol. 2009. PMID: 19417076
-
Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.J Clin Endocrinol Metab. 2010 May;95(5):2089-98. doi: 10.1210/jc.2009-2139. Epub 2010 Mar 5. J Clin Endocrinol Metab. 2010. PMID: 20207829 Clinical Trial.
-
Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.J Clin Endocrinol Metab. 1996 Nov;81(11):3902-8. doi: 10.1210/jcem.81.11.8923836. J Clin Endocrinol Metab. 1996. PMID: 8923836
-
Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop.J Clin Endocrinol Metab. 2008 Nov;93(11):4210-7. doi: 10.1210/jc.2008-0509. Epub 2008 Sep 9. J Clin Endocrinol Metab. 2008. PMID: 18782877
-
Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure.Pediatr Nephrol. 2005 Mar;20(3):290-4. doi: 10.1007/s00467-004-1714-7. Epub 2005 Jan 29. Pediatr Nephrol. 2005. PMID: 15682316 Review.
Cited by
-
Effect of Atomoxetine on Behavioral Difficulties and Growth Development of Primary School Children with Attention-Deficit/Hyperactivity Disorder: A Prospective Study.Children (Basel). 2022 Feb 6;9(2):212. doi: 10.3390/children9020212. Children (Basel). 2022. PMID: 35204932 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous